Cargando…
FBXO7 Confers Mesenchymal Properties and Chemoresistance in Glioblastoma by Controlling Rbfox2‐Mediated Alternative Splicing
Mesenchymal glioblastoma (GBM) is highly resistant to radio‐and chemotherapy and correlates with worse survival outcomes in GBM patients; however, the underlying mechanism determining the mesenchymal phenotype remains largely unclear. Herein, it is revealed that FBXO7, a substrate‐recognition compon...
Autores principales: | Li, Shangbiao, Chen, Yanwen, Xie, Yuxin, Zhan, Hongchao, Zeng, Yu, Zeng, Kunlin, Wang, Li, Zhan, Ziling, Li, Cuiying, Zhao, Liqian, Chen, Xiaoxia, Tan, Yujing, Wang, Zhongyong, Bu, Junguo, Song, Ye, Deng, Fan, Zhou, Aidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667838/ https://www.ncbi.nlm.nih.gov/pubmed/37822160 http://dx.doi.org/10.1002/advs.202303561 |
Ejemplares similares
-
Optimization of cancer immunotherapy through pyroptosis: A pyroptosis-related signature predicts survival benefit and potential synergy for immunotherapy in glioma
por: Zeng, Yu, et al.
Publicado: (2022) -
Derepression of the USP22-FASN axis by p53 loss under oxidative stress drives lipogenesis and tumorigenesis
por: Han, Zelong, et al.
Publicado: (2022) -
RBFOX1 and RBFOX3 Mutations in Rolandic Epilepsy
por: Lal, Dennis, et al.
Publicado: (2013) -
Correction: RBFOX1 and RBFOX3 Mutations in Rolandic Epilepsy
por: Lal, Dennis, et al.
Publicado: (2013) -
RBFOX2 and alternative splicing in B-cell lymphoma
por: Quentmeier, Hilmar, et al.
Publicado: (2018)